Bulletin
Investor Alert

Deciphera Pharmaceuticals Inc.

NAS: DCPH

GO
/marketstate/country/us

After Hours

/zigman2/quotes/203556943/composite

$

10.50

Change

-0.12 -1.13%

Volume

Volume 87,013

May 16, 2022, 5:51 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203556943/composite

Today's close

$ 10.31

$ 10.62

Change

+0.31 +3.01%

Day low

Day high

$10.10

$10.86

Open
Open: 10.24

52 week low

52 week high

$6.51

$38.91

Open

Market cap

$682.69M

Average volume

1.32M

P/E ratio

N/A

Rev. per Employee

$357,911

EPS

-4.90

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/dcph

MarketWatch News on DCPH

  1. Deciphera Pharmaceuticals downgraded to hold from buy at Truist

    9:04 a.m. Nov. 8, 2021

    - Tomi Kilgore

  2. Deciphera Pharmaceuticals downgraded to hold from buy at Stifel Nicolaus

    8:58 a.m. Nov. 8, 2021

    - Tomi Kilgore

  3. Deciphera Pharmaceuticals stock price target cut to $65 from $84 at Truist

    7:16 a.m. Oct. 4, 2021

    - Tomi Kilgore

  4. Deciphera Pharmaceuticals coverage resumed at Stifel with buy stock rating and $60 target price

    7:05 a.m. Sept. 30, 2021

    - Tonya Garcia

  5. Deciphera Pharmaceuticals started at buy with $75 stock price target at Stifel Nicolaus

    10:16 a.m. Dec. 3, 2020

    - Tomi Kilgore

  6. Callon, Fitbit, Genco Shipping, and Other 13D Filings

    10:30 p.m. Nov. 22, 2019

    - Barron's Online

  7. Deciphera Pharmaceuticals stock price target raised to $60 from $45 at SunTrust RH

    8:40 a.m. Aug. 14, 2019

    - Tomi Kilgore

  8. Deciphera Pharmaceuticals stock rockets 126% premarket after positive trial data for GIST treatment

    8:32 a.m. Aug. 13, 2019

    - Tomi Kilgore

  9. Deciphera Pharmaceuticals started at buy with $42 stock price target at Deutsche Bank

    2:17 p.m. July 18, 2019

    - Tomi Kilgore

  10. Deciphera Pharmaceuticals started at outperform with $47 stock price target at Raymond James

    8:25 a.m. Aug. 29, 2018

    - Tomi Kilgore

  11. Deciphera Pharmaceuticals started at buy with $60 stock price target at SunTrust RH

    7:54 a.m. July 5, 2018

    - Tomi Kilgore

  12. Deciphera Pharmaceuticals started at overweight with $30 stock price target at J.P. Morgan

    7:40 a.m. Oct. 23, 2017

    - Tomi Kilgore

Analyst Ratings

/news/nonmarketwatch/company/us/dcph

Other News on DCPH

  1. 10-Q: DECIPHERA PHARMACEUTICALS, INC.

    7:15 a.m. May 4, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  2. Notable earnings before Wednesday's open

    11:43 a.m. May 3, 2022

    - Seeking Alpha

  3. AstraZeneca (AZN) Q1 Earnings and Revenues Beat Estimates

    3:12 p.m. April 29, 2022

    - Zacks.com

  4. Emergent's (EBS) Q1 Earnings Miss, Revenues Beat Estimates

    2:25 p.m. April 29, 2022

    - Zacks.com

  5. BioMarin (BMRN) Q1 Earnings and Revenues Beat Estimates

    2:35 p.m. April 28, 2022

    - Zacks.com

  6. NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates

    8:45 a.m. April 27, 2022

    - Zacks.com

  7. 4 Reasons to Add Deciphera (DCPH) Stock to Your Portfolio

    12:08 p.m. April 22, 2022

    - Zacks.com

  8. Loading more headlines...
/news/pressrelease/company/us/dcph

Press Releases on DCPH

  1. Deciphera Pharmaceuticals Inc. (DCPH) Climbs to Annual-High Share Price

    12:26 p.m. April 6, 2022

    - Investor Brand Network

  2. Loading more headlines...

Rates »

Link to MarketWatch's Slice.